● Recruiting

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Condition: Diabetic Macular Edema · DME · Diabetic Macular Edema (DME) · Sponsor: EyePoint Pharmaceuticals, Inc.

PhasePhase 3

Planned participants240

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

This description comes directly from the study's public registry record.

Talk to the study team

Ramiro Ribeiro, MD, PhD · 833-393-7646 · rribeiro@eyepoint.bio

Always discuss trial participation with your own doctor first.

Locations (68)

Associated Retina Consultans	Gilbert, Arizona, United States	Recruiting
Associated Retina Consultants - Phoenix	Phoenix, Arizona, United States	Recruiting
Phoenix Retina Clinical Trials, LLC - North Phoenix	Phoenix, Arizona, United States	Recruiting
Retina Macula Institute of Arizona	Scottsdale, Arizona, United States	Recruiting
Retina Vitreous Associates Medical Group	Beverly Hills, California, United States	Recruiting
Retina Consultants of Orange County	Fullerton, California, United States	Recruiting
South Coast Retina Center	Long Beach, California, United States	Recruiting
Retinal Consultants Medical Group - Modesto	Modesto, California, United States	Recruiting
Kaiser Permanente	Oakland, California, United States	Recruiting
Retina Consultants of Southern California	Redlands, California, United States	Recruiting
Bay Area Retina Associates	Walnut Creek, California, United States	Recruiting
Retina Specialists of Colorado - Arvada	Arvada, Colorado, United States	Recruiting

+ 56 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07449923